273 related articles for article (PubMed ID: 9234828)
1. Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension.
Chan P; Lin CN; Tomlinson B; Lin TH; Lee YS
Am J Hypertens; 1997 Jul; 10(7 Pt 1):743-9. PubMed ID: 9234828
[TBL] [Abstract][Full Text] [Related]
2. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.
Ruddy TD; Fodor JG
Cardiovasc Drugs Ther; 1997 Sep; 11(4):581-90. PubMed ID: 9358963
[TBL] [Abstract][Full Text] [Related]
3. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril.
Black HR; Graff A; Shute D; Stoltz R; Ruff D; Levine J; Shi Y; Mallows S
J Hum Hypertens; 1997 Aug; 11(8):483-9. PubMed ID: 9322828
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trail.
Brozena SC; Johnson MR; Ventura H; Hobbs R; Miller L; Olivari MT; Clemson B; Bourge R; Quigg R; Mills RM; Naftel D
J Am Coll Cardiol; 1996 Jun; 27(7):1707-12. PubMed ID: 8636558
[TBL] [Abstract][Full Text] [Related]
5. Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring.
Karotsis AK; Symeonidis A; Mastorantonakis SE; Stergiou GS;
Clin Exp Hypertens; 2006 Oct; 28(7):655-62. PubMed ID: 17060064
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
Weir MR; Fagan T; Chrysant S; Flamenbaum W; Kaihlanen PM; Lueg M; Anzalone D
J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
[TBL] [Abstract][Full Text] [Related]
7. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled comparison of diltiazem and amlodipine monotherapy in essential hypertension using 24-h ambulatory monitoring.
Watts RW; Wing LM
Blood Press; 1998 Jan; 7(1):25-30. PubMed ID: 9551874
[TBL] [Abstract][Full Text] [Related]
9. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
Wu SC; Liu CP; Chiang HT; Lin SL
Heart Vessels; 2004 Jan; 19(1):13-8. PubMed ID: 14685749
[TBL] [Abstract][Full Text] [Related]
10. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
Weiss RJ; Stapff M; Lin Y
Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
[TBL] [Abstract][Full Text] [Related]
11. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
Applegate W; Cohen JD; Wolfson P; Davis A; Green S
Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of diltiazem and lisinopril on left ventricular structure and filling in mild-to-moderate hypertension.
van Leeuwen JT; Smit AJ; May JF; ten Berge BS; Hamer HP; Havinga TK; Schuurman FH; van der Veru E; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1995 Dec; 26(6):983-9. PubMed ID: 8606538
[TBL] [Abstract][Full Text] [Related]
13. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.
Messerli F; Frishman WH; Elliott WJ
Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873
[TBL] [Abstract][Full Text] [Related]
14. Lisinopril and diltiazem reduce left ventricular mass without changing blood pressure in normotensive subjects with exaggerated blood pressure response to exercise.
Polónia J; Martins L; Macedo F; Faria DB; Simões L; Brandão F; Gomes MC
Rev Port Cardiol; 1996 Mar; 15(3):185-93, 179. PubMed ID: 8634167
[TBL] [Abstract][Full Text] [Related]
15. [A multicenter study of lisinopril in the treatment of mild to moderate hypertension].
Yodfat Y
Harefuah; 1995 Jul; 129(1-2):26-9, 78. PubMed ID: 7557704
[TBL] [Abstract][Full Text] [Related]
16. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
17. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and tolerability of nebivolol versus lisinopril in the treatment of essential arterial hypertension: a randomized, multicentre, double-blind study.
Rosei EA; Rizzoni D; Comini S; Boari G;
Blood Press Suppl; 2003 May; 1():30-5. PubMed ID: 12800985
[TBL] [Abstract][Full Text] [Related]
20. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study.
Fogari R; Zoppi A; Carretta R; Veglio F; Salvetti A;
J Hypertens; 2002 May; 20(5):1007-14. PubMed ID: 12011663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
